Bibliographic Info
GuidelineWHO guidelines for malaria, 16 October 2023.
Year of Publication2023
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended against
Conditional
Certainty of evidence
Very low
Short-course standard high-dose primaquine treatment (2022): To prevent relapse, an additional treatment option of using primaquine 1.0 mg/kg/day for seven days to treat P. vivax or P. ovale malaria is not recommended.